151 related articles for article (PubMed ID: 31873945)
1. Radiotherapy in mantle cell lymphoma: A literature review.
Ben Barouch S; Kuruvilla J; Tsang RW; Yashphe E; Sarid N
Hematol Oncol; 2020 Aug; 38(3):223-228. PubMed ID: 31873945
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patients.
Haque W; Voong KR; Shihadeh F; Arzu I; Pinnix C; Mazloom A; Medeiros LJ; Romaguera J; Rodriguez A; Wang M; Allen P; Dabaja B
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):474-9. PubMed ID: 25108680
[TBL] [Abstract][Full Text] [Related]
3. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT).
Rosenbluth BD; Yahalom J
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1185-91. PubMed ID: 16682133
[TBL] [Abstract][Full Text] [Related]
4. Management Trends and Outcomes for Stage I to II Mantle Cell Lymphoma Using the National Cancer Data Base: Ascertaining the Ideal Treatment Paradigm.
Gill BS; Vargo JA; Pai SS; Balasubramani GK; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):668-76. PubMed ID: 26461009
[TBL] [Abstract][Full Text] [Related]
5. Limited-stage mantle-cell lymphoma.
Leitch HA; Gascoyne RD; Chhanabhai M; Voss NJ; Klasa R; Connors JM
Ann Oncol; 2003 Oct; 14(10):1555-61. PubMed ID: 14504058
[TBL] [Abstract][Full Text] [Related]
6. Effect of radiotherapy on the survival of patients with stage I and stage II mantle cell lymphoma: analysis of the Surveillance, Epidemiology and End Results database.
Guru Murthy GS; Venkitachalam R; Mehta P
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S90-5. PubMed ID: 25486963
[TBL] [Abstract][Full Text] [Related]
7. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Pinnix CC; Dabaja BS; Milgrom SA; Smith GL; Abou Z; Nastoupil L; Romaguera J; Turturro F; Fowler N; Fayad L; Westin J; Neelapu S; Fanale MA; Rodriguez MA; Hagemeister F; Lee HJ; Oki Y; Wang M; Samaniego F; Chi L; Esmaeli B
Head Neck; 2017 Jun; 39(6):1095-1100. PubMed ID: 28370694
[TBL] [Abstract][Full Text] [Related]
8. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
[TBL] [Abstract][Full Text] [Related]
9. Centroblastic-centrocytic non-Hodgkin's lymphoma stage I-III: patterns of failure following radiotherapy.
Frank C; Zierhut D; Schulz-Ertner D; Wannenmacher M
Strahlenther Onkol; 2001 Nov; 177(11):597-603. PubMed ID: 11757182
[TBL] [Abstract][Full Text] [Related]
10. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
11. Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital.
Bernard M; Tsang RW; Le LW; Hodgson DC; Sun A; Wells W; Kukreti V; Kuruvilla J; Crump M; Gospodarowicz MK
Leuk Lymphoma; 2013 Feb; 54(2):261-7. PubMed ID: 22793378
[TBL] [Abstract][Full Text] [Related]
12. Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas.
Puvvada SD; Guillen-Rodriguez J; Kumar A; Inclán L; Heard K; Rivera XI; Anwer F; Schatz JH; Mahadevan D; Persky DO
Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):58-64. PubMed ID: 29056470
[TBL] [Abstract][Full Text] [Related]
13. Lipidoid nanoparticle mediated silencing of Mcl-1 induces apoptosis in mantle cell lymphoma.
Knapp CM; He J; Lister J; Whitehead KA
Exp Biol Med (Maywood); 2016 May; 241(9):1007-13. PubMed ID: 27022142
[TBL] [Abstract][Full Text] [Related]
14. Involved-field radiotherapy for patients with mantle cell lymphoma.
Neville KE; Bisquera A; Capp AL
J Med Imaging Radiat Oncol; 2015 Oct; 59(5):631-9. PubMed ID: 26112608
[TBL] [Abstract][Full Text] [Related]
15. Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure.
Russo AL; Chen YH; Martin NE; Vinjamoori A; Luthy SK; Freedman A; Michaelson EM; Silver B; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):121-7. PubMed ID: 23414765
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
[TBL] [Abstract][Full Text] [Related]
17. Current overview and treatment of mantle cell lymphoma.
Schieber M; Gordon LI; Karmali R
F1000Res; 2018; 7():. PubMed ID: 30109020
[TBL] [Abstract][Full Text] [Related]
18. High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).
Weide R; Hess G; Köppler H; Heymanns J; Thomalla J; Aldaoud A; Losem C; Schmitz S; Haak U; Huber C; Unterhalt M; Hiddemann W; Dreyling M;
Leuk Lymphoma; 2007 Jul; 48(7):1299-306. PubMed ID: 17613757
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
[TBL] [Abstract][Full Text] [Related]
20. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Specht L
Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
